To distinguish GBM cells from the normal brain tissue, the FFPE sections were immunohistochemically stained with an anti-Vimentin antibody, leading to immunopositivity of the GBM tumor cells while leaving the normal murine brain tissue unstained. The gene discussed is VIM; the disease is glioblastoma.